跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vamzar Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Vamzar Plus
Approved
STANDARD
Vamzar Plus
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
04d3f47dd232534a
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
04d3f47dd232534a
Drug Approval Philippines Name
Vamzar Plus
Product Name
Vamzar Plus
Registration Number
DR-XY43598
Brand Name
Vamzar Plus
Generic Name
Losartan Potassium + Hydrochlorothiazide
Dosage Form
Fim-Coated Tablet
Dosage Strength
50 mg/12.5 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Ultramed Pharma Inc.
Issuance Date
26 April 2024
Expiry Date
06 August 2029
Pharmacologic Category
Angiotensin II Receptor Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
04d3f47dd232534a
Type
Standard
Back to Philippines FDA Approvals